VISHAL KOCHAR: Open Payments
NPI 1649667999 · BLOOMFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 35 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $122 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $92 |
| Exact Sciences Corporation | 4 | $84 |
| PFIZER INC. | 3 | $76 |
| Amgen Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| ABBVIE INC. | 2 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Tonix Medicines, Inc. | 1 | $43 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
Products named: NURTEC ODT, KRYSTEXXA, Ozempic, Cologuard Collection Kit, Wegovy, MOUNJARO, TONMYA, The Cologuard Plus Collection Kit.
Industry payments across CT — which companies pay providers there.
